Plaintiffs Exit Bayer MDL But Still Face Discovery
A federal judge has allowed 10 of 15 named plaintiffs to drop their class action claims in multidistrict litigation alleging Bayer Corp. failed to obtain regulatory approvals for two aspirin drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article